Regeneron Pharmaceuticals, Inc. (REGN)
612.76
-22.69
(-3.57%)
USD |
NASDAQ |
Jun 08, 15:37
Regeneron Pharmaceuticals EPS Diluted (Quarterly) : 6.752 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3861 |
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| Gilead Sciences, Inc. | 1.612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 727.20M |
| Revenue (Quarterly) | 3.605B |
| Total Expenses (Quarterly) | 2.878B |
| Enterprise Value | 60.67B |
| Gross Profit Margin (Quarterly) | 78.02% |
| Profit Margin (Quarterly) | 20.17% |
| Earnings Yield | 6.70% |
| Operating Earnings Yield | 5.82% |
| Normalized Earnings Yield | 6.772 |